| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
| 02/14/2007 | CN1299777C Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 02/13/2007 | US7176317 Anthraquinone, xanthene dyes |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | CA2358840C Methods and kits comprising an estrogen agonist/antagonist for improving vascular health |
| 02/13/2007 | CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 02/08/2007 | WO2007016423A2 Method for enantioselective hydrogenation of chromenes |
| 02/08/2007 | WO2007015112A1 Antitumoral compounds |
| 02/08/2007 | US20070032667 Route to alpha-tocopheryl alkanoates and percursors thereof |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032544 Medicinal acidic cannabinoids |
| 02/08/2007 | US20070032543 Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients |
| 02/08/2007 | DE102004032440B4 Verwendung von trisubstituierten Benzopyranonen Use of trisubstituted Benzopyranonen |
| 02/08/2007 | CA2617665A1 Method for enantioselective hydrogenation of chromenes |
| 02/08/2007 | CA2615592A1 Antitumoral compounds |
| 02/07/2007 | CN1910167A Selective estrogen receptor modulators for the treatment of vasomotor symptoms |
| 02/07/2007 | CN1910135A Amino alcohol derivatives and their activity as renin inhibitors |
| 02/07/2007 | CN1907979A 8-methylene-methylamine-5,7-dihydroxy-6,4'-dimethoxyisoflavone and medicinal composition with the same as active component |
| 02/07/2007 | CN1298741C Process for extracting protein, total flavone and super oxide dismutase from sea-buckthorn fresh branch and leaf |
| 02/07/2007 | CN1298722C Indole carbazole alkaloid and its preparing method and use |
| 02/06/2007 | US7173139 Enantioselective 1,4-addition of aromatic nucleophiles to α,β-unsaturated aldehydes using chiral organic catalysts |
| 02/06/2007 | US7173132 Certain substituted 1-aryl-3-piperazine-1′-yl propanones |
| 02/06/2007 | US7173130 Detection of transmembrane potentials by optical methods |
| 02/06/2007 | US7173125 Triphosphate oligonucleotide modification reagents and uses thereof |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/01/2007 | WO2006073457A3 Bioactive compounds and methods of uses thereof |
| 02/01/2007 | WO2006060196A3 Use of rottlerin and its derivatives as activators of bk channel for therapy of hypertension and related disorders |
| 02/01/2007 | US20070027329 Method for enantioselective hydrogenation of chromenes |
| 02/01/2007 | US20070027124 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070027123 Administering an estrogen receptor for treatment of osteoporosis, breast cancer, hypercholesteremia, hyperlipidemia or artheriosclerosis by administering estrogen modulators |
| 02/01/2007 | US20070027122 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070026384 Detection of transmembrane potentials by optical methods |
| 01/31/2007 | EP1747211A1 Process for preparing unsaturated lactones |
| 01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 01/31/2007 | CN1903233A Method for increasing yield of prodn. of hypericum japonicum total flavone |
| 01/31/2007 | CN1297552C Process for synthesizing luteolin |
| 01/30/2007 | US7169943 Manufacture of tocopheryl acetate |
| 01/30/2007 | US7169942 Cannabinoid derivatives, methods of making, and use thereof |
| 01/30/2007 | US7169941 uniform dispersion containing a chromene compound in a polymer matrix in a high concentration; can easily and simply provide photochromism to an optical article by applying a curable composition as a coating |
| 01/30/2007 | US7169939 Linkers for donor dyes to acceptor dyes for energy transfer between dyes with fluorescence |
| 01/30/2007 | US7169747 For detergents/fabric softeners; improved organoleptic properties |
| 01/30/2007 | US7169558 Using non-radioactive markers to identify nascent proteins translated within cellular or cell-free translation systems; bioremediation and pollution contol of biohazards |
| 01/30/2007 | US7169446 photocurable ink composition for ink jet recording containing a cation polymerizable oxetane compound with high reactivity which can provide a high quality image, and an image formation method employing the photocurable ink composition |
| 01/30/2007 | CA2440383C 7,9-substituted tetracycline compounds |
| 01/25/2007 | WO2007009388A1 Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof |
| 01/25/2007 | WO2007009143A2 Method for producing nebivolol |
| 01/25/2007 | WO2005090336A8 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands |
| 01/25/2007 | US20070021384 Compounds for use in the treatment of infection |
| 01/25/2007 | US20070020643 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered |
| 01/25/2007 | CA2615832A1 Method for producing nebivolol |
| 01/24/2007 | EP1745015A1 Bicyclic aromatic sulfinyl derivatives |
| 01/24/2007 | CN1902189A Plant-origin beta3-adrenoceptor agonist and use of the same |
| 01/24/2007 | CN1900081A Water soluble artemisine derivative and its preparing method, medicinal composition and use |
| 01/24/2007 | CN1900067A Tricyclic compounds, their production and use |
| 01/24/2007 | CN1899344A Process for preparing blumea balsamifera total flavone extract and blumea balsamifera flavone extract |
| 01/24/2007 | CN1899341A American goldenrod herb total flavone extract and its preparing method and use |
| 01/24/2007 | CN1899340A Beggarticks extract and its use |
| 01/24/2007 | CN1899250A Application of biological active matteri-abric ketone cellulose and its dervivative |
| 01/24/2007 | CN1296338C Hypericum sampsonii hance total extract, and its preparing method and use |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166640 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/18/2007 | WO2007008200A1 Wortmannin analogs and methods of using same in combination with chemotherapeutic agents |
| 01/18/2007 | WO2007008037A1 Novel chromen-2-one based hydroxamic acid derivatives having anti-inflammatory activity, the preparation thereof and a composition containing the same for treating inflammatory disease |
| 01/18/2007 | US20070015820 1,3-Diacetyl-8-hydroxy-2-(7-hydroxychromanon-3-yl)-9H-xanthen-9-ones; obtained from a culture of the Penicillium strain SPF-3059; prevents growth cone collapse |
| 01/18/2007 | US20070015817 4-((4-(2-pyrrolidinylethoxy)phenyl)methyl)-3-(4-(trifluoromethyl)phenyl)-7-hydroxychromen-2one, pharmaceutically acceptable salts thereof and methods of use therewith |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | CA2578336A1 Wortmannin analogs and methods of using same in combination with chemotherapeutic agents |
| 01/17/2007 | EP1743881A1 Phenyl-benzyl-ketones |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1401575B1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/17/2007 | CN1898230A Process for purifying (-)-delta 9-trans-tetrahydrocannabinol |
| 01/17/2007 | CN1295231C Bromo-dihydroartemisine |
| 01/17/2007 | CN1295230C Production of high-purity glabrene |
| 01/17/2007 | CN1295224C Process for preparing epimedium total flavone for injection |
| 01/16/2007 | CA2257234C Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 01/11/2007 | WO2007005248A2 IMPROVED PROCESSES FOR THE PREPARATION OF PROTECTED -(+)-CATECHIN AND (-)-EPICATECHIN NOMOMERS, FOR COUPLING THE PROTECTED MONOMERS WITH AN ACTIVATED, PROTECTED EPICATECHIN MONOMER, AND FOR THE PREPARATION OF EPICATECHIN-(4β, 8)-EPICATECHIN OR -CATECHIN DIMERS AND THEIR DIGALLATES |
| 01/11/2007 | WO2006099193A3 Chromen-4-one inhibitors of anti-apoptotic bcl-2 family members and the uses thereof |
| 01/11/2007 | WO2006083692A3 Methods of identifying modulators of bromodomains |
| 01/11/2007 | WO2006079731A3 Use of cacao polyphenols for treating a prostate hyperplasia, a specific cacao extract and applications |
| 01/11/2007 | US20070010691 Enantioselective synthesis of enantiomerically enriched compounds |
| 01/11/2007 | US20070010575 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/11/2007 | US20070010422 Improved bioavailability; for oral and intracolonic administration |
| 01/11/2007 | US20070009619 Neutralizing agent for cavitating toxin |
| 01/11/2007 | CA2611878A1 Improved processes for the preparation of protected -(+)-catechin and (-)-epicatechin monomers, for coupling the protected monomers with an activated, protected epicatechin monomer, and for the preparation of epicatechin-(4.beta.,8)-epicatechin or -catechin dimers and their digallates |
| 01/10/2007 | EP1741693A1 Process for production of optically active alcohols |
| 01/10/2007 | EP1740567A1 Process for the manufacture of tocopheryl acylates |
| 01/10/2007 | EP1740225A2 Contrast agents for myocardial perfusion imaging |
| 01/10/2007 | EP1314730B1 Reagent for determining singlet oxygen |
| 01/10/2007 | CN1894233A Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2h-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them |
| 01/10/2007 | CN1894190A Method for the production of tetrahydrogeranylacetone |
| 01/10/2007 | CN1893957A Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
| 01/10/2007 | CN1891699A Therapeutic morpholino-substituted compounds |
| 01/10/2007 | CN1891693A Therapeutic morpholino-substituted compounds |
| 01/10/2007 | CN1294128C Polyester polycarbonates made from special diphenols |
| 01/09/2007 | US7161055 molecular distillation of esterified oil, especially palm oil, giving a concentrate rich in minor components, such as squalene, carotenes, tocols and sterols; dilution of the concentrate in a non-polar solvent; adsorption; solvent extraction; desorption |
| 01/09/2007 | US7161042 Protected diols for prostaglandin synthesis |
| 01/09/2007 | US7160920 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 01/09/2007 | US7160904 Nicotine in therapeutic angiogenesis and vasculogenesis |